Paras Vora, MD
Ophthalmology · Lexington, KYNPI 1336778570
Payments from drug & device makers
What this record shows
Alcon accounts for 73.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $2,642 and has fallen 65.6% since, to $909 in 2025.
Across 26 payments — averaging $160.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- AbbVie$174
- Glaukos Corporation$171
- Apellis Pharmaceuticals, Inc.$142
- Regeneron Healthcare Solutions, Inc.$139
- Astellas Pharma US Inc$110
- plus $357 from 5 others
What the payments were for
- Travel & lodging$1,87045%
- Food & beverage$2,31155%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 13 | $3,089 |
| AbbVie | 2 | $174 |
| Glaukos Corporation | 1 | $171 |
| Apellis Pharmaceuticals, Inc. | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. | 2 | $139 |
| Astellas Pharma US Inc | 1 | $110 |
| Rxsight Inc | 1 | $105 |
| Bausch & Lomb Americas Inc. | 1 | $98 |
| Regeneron | 1 | $97 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Genentech USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$391
- Unity$272
- iDoseTR$171
- Syfovre$116
- EYLEA$113
- Izervay$110
- AcrySof IQ VIVITY IOL$107
- RXSIGHT CONTACT LENS$105
- RXSIGHT INJECTOR CARTRIDGE$105
- RXSIGHT INJECTOR HANDPIECE$105
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$105
- LIGHT ADJUSTABLE LENS (LAL)$105
- OZURDEX$104
- Constellation$101
How this compares
$4,182 in reported general payments places this provider in the 75th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 25 | $842 |
| ValacyclovirValacyclovir Hcl | 14 | $357 |
| ErythromycinErythromycin Base | 21 | $207 |
| Timolol Maleate | 17 | $175 |
| Latanoprost | 21 | $79 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Lexington
- Gary WortzLexington$159K
- Bruce KofflerLexington$49K
- Asim PirachaLexington$17K
- Ryan SmithLexington$12K
- Angelia ThompsonLexington$11K
- James HuffmanLexington$10K
- Shivani ReddyLexington$8K
- Michael TannerLexington$4K
- Edward HollandEdgewood$678K
- Jeremy ClarkLouisville$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.